Gen. H.R. McMaster to retire from NRX Pharmaceuticals Board at next annual meeting

NRX Pharmaceuticals, Inc.

Gen. McMaster informed the Board on Feb 7, 2022 that he will retire effective the next Annual Meeting.
His term would have expired in 2024; he will continue as director until the Annual Meeting.
No disagreement with the Company cited; McMaster will remain as an advisor.
Board thanked McMaster for service; company developing NRX-101 for suicidal depression and PTSD.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gen. H.R. McMaster

director

NRXP · NRX Pharmaceuticals, Inc.

Filed: February 11, 2022, 6:59 PM ET

On February 7, 2022, one of the Company’s directors Gen. H.R. McMaster informed the Board that he would be retiring from the Board with effect from the next Annual Meeting of Shareholders (the “Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gen. H.R. McMaster departed as director at NRX Pharmaceuticals, Inc..

Action: retiring
Role: director

Exact text from the filing

On February 7, 2022, one of the Company’s directors Gen. H.R. McMaster informed the Board that he would be retiring from the Board with effect from the next Annual Meeting of Shareholders (the “Annual Meeting”).

View on SEC.gov

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-001035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.